ArticleLangmuir : the ACS journal of surfaces and colloids2025
Fn14-Targeted Gold Nanorods for Augmenting Laser Thermal Therapy for High-Grade Gliomas.
Article in Langmuir : the ACS journal of surfaces and colloids, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Rituximab-Conjugated DART Nanoformulation for CD20-Targeted Drug Delivery in Non-Hodgkin Lymphoma.International journal of nanomedicine · 2026Article
- Intravoxel Incoherent Motion Diffusion-weighted MR Imaging for Monitoring the Therapeutic Efficacy of Interventional Photothermal Therapy with Nanoparticles in Rabbit VX2 TumorsCurrent medical imaging · 2026Article
- Colloidal Chemistry and Nanostructure Engineering of Gold Nanorods for Glioblastoma Applications.ACS omega · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Glioblastoma (GBM) is a highly aggressive and invasive brain tumor. Tumor recurrence after standard surgery, chemotherapy, and radiation is nearly universal. Unfortunately, only around 25% of GBM patients undergo repeat surgery. Laser interstitial thermal therapy (LITT) is a promising strategy to treat patients with inoperable or recurrent GBM. While advances in magnetic resonance thermometry and laser probe cooling systems have provided significant safety improvements, the full potential of laser thermal therapy is still hindered by the lack of selective targeting of GBM cells. Gold nanorods (GNR) are attractive plasmonic antennas that can efficiently convert laser energy to localized heat for hyperthermal therapy and can be used as contrast agents for computed tomography (CT) imaging. Here, we surface-functionalized GNR with antifibroblast growth factor-inducible 14 (Fn14) antibody and polyethylene glycol to achieve GBM selectivity with low adhesivity to extracellular matrix. Red light activation (690 nm, 2.5 W/cm
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.